AARTIPHARMNSEAarti Pharmalabs LimitedMinimalNeutral
Announced Sat, 4 Apr · 16:59 IST

Aarti Pharmalabs Limited has informed the Exchange regarding ' Intimation Regarding Second 100-Day Campaign - ''Saksham Niveshak''.

AARTIPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.6%1-day move
₹642.00
prior close
₹655.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.8-2.5-3.5-2.4+0.6+7.3+5.7+7.5+8.1+8.6+10.7+23.1-5.3+9.5
Up moveDown movePending
AI summary

Aarti Pharmalabs has informed exchanges about the IEPFA's Second 100-Day Campaign 'Saksham Niveshak' running from April 1 to July 9, 2026. The campaign aims to help shareholders claim their unpaid or unclaimed dividends before they are transferred to the Investor Education and Protection Fund. Shareholders are advised to update their KYC details including PAN, nomination, contact information, bank account details, and specimen signature with the RTA MUFG Intime India or their Depository Participant. The company will send letters/emails with details of unpaid dividends. Shareholders must act by July 9, 2026, to avoid their dividends being transferred to IEPF.

Likely market impact

This is an investor awareness initiative with no direct impact on stock price. Shareholders with unclaimed dividends should update their details promptly to receive outstanding payments.